STOCK TITAN

Inflection Point V extends GOWell redemption deadline

Inflection Point Acquisition Corp. V (IPEX) reports an administrative change related to its pending business combination with GOWell Technology Limited.

(Very High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Inflection Point Acquisition Corp. V (IPEX) reports an administrative change related to its pending business combination with GOWell Technology Limited. The deadline for shareholders to submit or amend redemption requests in connection with the Business Combination has been extended from 5:00 p.m. Eastern Time on September 1, 2026 to 5:00 p.m. Eastern Time on September 2, 2026. Shareholders who previously submitted redemption requests may withdraw them by contacting Continental Stock Transfer and Trust Company by 5:00 p.m. New York Time on September 2, 2026; those who do not wish to withdraw need not take further action. A registration statement covering the transaction, including a Proxy Statement/Prospectus, was declared effective by the SEC on August 11, 2026 and the definitive Proxy Statement/Prospectus was mailed to shareholders of record as of June 30, 2026.

Positive

  • None.

Negative

  • None.

Filing Explained

The redemption window now ends September 2, 2026, while the proposed combination remains incomplete and shareholders can withdraw prior requests.

As a Form 8-K, this report discloses a specified material event: IPEX extended the deadline for delivering redemption requests in connection with its proposed business combination from September 1, 2026 to September 2, 2026.

The business combination with GOWell is still described as proposed, so this filing changes the timing for shareholder redemption decisions rather than reporting a completed combination.

Shareholders may withdraw previously submitted redemption requests by contacting IPEX’s transfer agent before 5:00 p.m. Eastern Time on September 2, 2026; shareholders who do not withdraw those requests need take no further action.

The registration statement was declared effective on August 11, 2026, and the definitive Proxy Statement/Prospectus was mailed to shareholders of record as of June 30, 2026.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
New redemption deadline 5:00 p.m. Eastern Time on September 2, 2026 Extended deadline for redemption requests related to the Business Combination
Prior redemption deadline 5:00 p.m. Eastern Time on September 1, 2026 Previously disclosed cutoff time for redemption requests
Registration Statement effectiveness date August 11, 2026 Date SEC declared the Registration Statement, including Proxy Statement/Prospectus, effective
Record date for shareholders June 30, 2026 Record date for IPEX shareholders entitled to vote on the Business Combination
Class A ordinary share par value $0.0001 per share Par value of IPEX Class A ordinary shares listed on Nasdaq
Business Combination Agreement regulatory
"entered into a Business Combination Agreement (as amended on December 22, 2025 and July 13, 2026"
A business combination agreement is a detailed contract that lays out the terms for two companies to join together—covering price, how ownership will be split, the steps needed to close the deal, and what each side promises to do or avoid before closing. For investors it matters because the agreement determines potential changes in value, control, timing, and risk exposure—think of it like the playbook for a merger that shows who wins, who pays, and what could still derail the plan.
Proxy Statement/Prospectus regulatory
"which includes the Proxy Statement/Prospectus. The definitive Proxy Statement/Prospectus was mailed"
A proxy statement or prospectus is a document that companies send to shareholders to provide important information about upcoming decisions or investments, such as voting on company issues or offering new shares to the public. It helps investors understand the details and risks involved, enabling them to make informed choices about their ownership or involvement with the company.
Registration Statement regulatory
"have prepared and filed with the SEC a registration statement (the “Registration Statement”)"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
redemption requests financial
"deadline of 5:00 p.m. Eastern Time on September 1, 2026 for delivery of redemption requests"
Redemption requests are investor demands to turn holdings in a fund or redeemable security into cash, effectively asking the issuer or manager to return their invested money. Large or sudden volumes of these requests matter because they can force managers to sell assets quickly, lower the value of remaining investors' holdings, and strain a fund’s ability to meet payouts — like many customers lining up at once to withdraw cash from a bank, potentially causing liquidity problems.
forward-looking statements regulatory
"include or may include “forward-looking statements” regarding, among other things, the plans"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

What did IPEX disclose in this 8-K about the GOWell business combination?

IPEX disclosed that in connection with its proposed Business Combination with GOWell, the deadline for redemption requests has been extended to 5:00 p.m. Eastern Time on September 2, 2026, and it reminded shareholders of the availability of the Proxy Statement/Prospectus and related SEC filings.

What is the new redemption deadline for IPEX shareholders regarding the business combination?

The new deadline for IPEX shareholders to submit or amend redemption requests in connection with the Business Combination is 5:00 p.m. Eastern Time on September 2, 2026. Previously, the deadline had been 5:00 p.m. Eastern Time on September 1, 2026.

How can IPEX shareholders withdraw previously submitted redemption requests?

Shareholders can withdraw previously submitted redemption requests by contacting Continental Stock Transfer and Trust Company, IPEX’s transfer agent, and requesting return of their shares by 5:00 p.m. New York Time on September 2, 2026.

When was the registration statement for the IPEX business combination declared effective?

The registration statement for the IPEX Business Combination, which includes the Proxy Statement/Prospectus, was declared effective by the SEC on August 11, 2026. The definitive Proxy Statement/Prospectus was mailed to shareholders of record as of June 30, 2026.

What is the record date for IPEX shareholders entitled to vote on the business combination?

The record date for IPEX shareholders entitled to vote on the Business Combination is June 30, 2026, as stated in connection with mailing of the definitive Proxy Statement/Prospectus.

Where can investors find more information about the IPEX and GOWell business combination?

Investors can access the Registration Statement, Proxy Statement/Prospectus and related filings for free at www.sec.gov or by requesting copies from Inflection Point Acquisition Corp. V at its New York address listed in the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0002028355 00-0000000 0002028355 2026-08-31 2026-08-31 0002028355 IPEX:UnitsEachConsistingOfOneClassOrdinaryShareAndOneRightMember 2026-08-31 2026-08-31 0002028355 IPEX:ClassOrdinarySharesParValue0.0001PerShareMember 2026-08-31 2026-08-31 0002028355 IPEX:RightsEachRightEntitlingHolderToReceiveOnefifth15OfOneClassOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember 2026-08-31 2026-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 31, 2026

 

INFLECTION POINT ACQUISITION CORP. V

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-42518   N/A
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

167 Madison Ave, Suite 205 #1017
New York, NY 10016

(Address of principal executive offices, including zip code)

 

212-476-6908
(Registrant’s telephone number, including area code)

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one right   IPEXU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   IPEX   The Nasdaq Stock Market LLC
Rights, each right entitling the holder to receive one-fifth (1/5) of one Class A ordinary share upon the completion of the Company’s initial business combination   IPEXR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01 Other Events

 

As previously disclosed, on October 13, 2025, Inflection Point Acquisition Corp. V (formerly known as Maywood Acquisition Corp.), a Cayman Islands exempted company (“IPEX”), GOWell Technology Limited, a Cayman Islands exempted company (“GOWell”), GOWell Energy Technology, a Cayman Islands exempted company (“PubCo”), and IPCV Merger Sub Limited, a Cayman Islands exempted company, entered into a Business Combination Agreement (as amended on December 22, 2025 and July 13, 2026, the “Business Combination Agreement”) with respect to a proposed business combination between IPEX and GOWell (the “Business Combination”).

 

The previously disclosed deadline of 5:00 p.m. Eastern Time on September 1, 2026 for delivery of redemption requests in connection with the Business Combination has been extended to 5:00 p.m. Eastern Time on September 2, 2026. Shareholders who wish to withdraw their previously submitted redemption requests may do so prior to the new redemption deadline by directly contacting and requesting that Continental Stock Transfer and Trust Company, IPEX’s transfer agent, return such shares by 5:00 p.m. New York Time on September 2, 2026. Shareholders who do not wish to withdraw their previously submitted redemption requests need not take any further action.

 

Additional Information and Where to Find It

 

In connection with the Business Combination, IPEX, GOWell and PubCo have prepared and filed with the SEC a registration statement (the “Registration Statement”), which was declared effective by the SEC on August 11, 2026, and which includes the Proxy Statement/Prospectus. The definitive Proxy Statement/Prospectus was mailed to IPEX’s shareholders of record as of June 30, 2026, the record date established for voting on the Business Combination. IPEX and/or PubCo may also file other relevant documents regarding the Business Combination with the SEC, including supplements to the Proxy Statement/Prospectus. This Current Report on Form 8-K does not contain all the information that should be considered concerning the Business Combination and other matters and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. Before making any voting or investment decision, IPEX’s shareholders and other interested persons are urged to read the Proxy Statement/Prospectus, as supplemented from time to time, and other documents filed in connection with the Business Combination, because these documents will contain important information about IPEX, GOWell, PubCo and the Business Combination. Shareholders will also be able to obtain free copies of the Registration Statement, the Proxy Statement/Prospectus and other documents filed with the SEC, once available, without charge, at the SEC’s website located at www.sec.gov, or by directing a request to Inflection Point Acquisition Corp. V, 167 Madison Ave, Suite 205 #1017, New York, NY 10016.

 

Participants in the Solicitation

 

IPEX, GOWell, and their directors and executive officers and other persons may be deemed to be participants in the solicitations of proxies from IPEX’s shareholders in respect of the Business Combination and the other matters set forth in the Registration Statement. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests by security holdings or otherwise, are contained in the Proxy Statement/Prospectus.

 

No Offer or Solicitation

 

This Current Report on Form 8-K and the exhibits hereto are for informational purposes only and are neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the Business Combination or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

 

1

 

 

Forward-Looking Statements

 

This Current Report on Form 8-K and the exhibits hereto include or may include “forward-looking statements” regarding, among other things, the plans, strategies and prospects, both business and financial, of IPEX, PubCo and GOWell. These statements are based on the beliefs and assumptions of the management of IPEX, PubCo and GOWell. Although the parties believe that their respective plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, none of IPEX, PubCo or GOWell can assure you that they will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “predicts,” “projects,” “forecasts,” “may,” “might,” “will,” “could,” “should,” “would,” “seeks,” “plans,” “scheduled,” “possible,” “continue,” “potential,” “anticipates” or “intends” or similar expressions; provided that the absence of these does not mean that a statement is not forward-looking. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this Current Report on Form 8-K might not occur, and actual results could differ materially from those anticipated in these forward-looking statements.

 

Important factors that could cause actual results to differ materially from those discussed in the forward-looking statements include: general economic, political and business conditions; the inability of the parties to consummate the transactions contemplated by the Business Combination Agreement; the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement; the number of redemption requests made by the IPEX’s shareholders in connection with the Business Combination; the outcome of any legal proceedings that may be instituted against the parties following the announcement of the transactions; the risk that IPEX shareholder approval for the Business Combination is not obtained; the anticipated capitalization and enterprise value of PubCo following the consummation of the Business Combination; the ability of PubCo to issue equity, equity-linked or other securities in the future; failure to realize the anticipated benefits of the transactions contemplated by the Business Combination Agreement, including as a result of a delay in consummating the Business Combination; the risk that the Business Combination may not be completed by IPEX’s business combination deadline and the potential failure to obtain an extension of its business combination deadline; the risks related to the rollout of GOWell’s business and the timing of expected business milestones; the ability of PubCo to execute its growth strategy, manage growth profitably and retain its key employees; the ability of PubCo to obtain or maintain the listing of its securities on the Nasdaq Stock Market LLC following the Business Combination; and other risks and uncertainties indicated in the Proxy Statement/Prospectus. Undue reliance should not be placed upon the forward-looking statements.

 

These forward-looking statements are made only as of the date of this Current Report on Form 8-K. Neither IPEX, PubCo, nor any of their respective affiliates undertake any obligation to publicly update or revise any forward-looking statement contained in this Current Report on Form 8-K, whether as a result of new information, future events or otherwise, except as required by law.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 31, 2026

 

  INFLECTION POINT ACQUISITION CORP. V
     
  By:  /s/ Michael Blitzer
    Name:  Michael Blitzer
    Title: Chief Executive Officer

 

3

Filing Exhibits & Attachments

4 documents